Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
4
33%
Ph phase_3
3
25%
Ph not_applicable
5
42%

Phase Distribution

0

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
4(33.3%)
Phase 3Large-scale testing
3(25.0%)
N/ANon-phased studies
5(41.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(10)
Terminated(1)
Other(1)

Detailed Status

Completed10
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
90.9%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (33.3%)
Phase 33 (25.0%)
N/A5 (41.7%)

Trials by Status

completed1083%
terminated18%
unknown18%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials
NCT05227755Not Applicable

High-protein Oral Supplement Improves Normalized Protein Catabolic Rate and Inflammation Markers

Completed
NCT05052827Not Applicable

Determining the Effect of Protein Quality on Post-exercise Anabolism in Active Youth

Unknown
NCT04864769Not Applicable

Effect of Intake of Hydrolyzed Krill Protein Isolate on Plasma Amino Acid Profile

Completed
NCT00064194Phase 3

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

Completed
NCT00345813Phase 2

Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer

Completed
NCT00343434Not Applicable

Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight

Completed
NCT00031746Phase 2

Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels

Completed
NCT00765479Phase 2

Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer

Completed
NCT00003367Phase 3

Diet and PSA Levels in Patients With Prostate Cancer

Completed
NCT00243048Phase 2

Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer

Completed
NCT00036686Not Applicable

Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy

Terminated
NCT00004654Phase 3

Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia

Completed

All 12 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
12